ARCHIVES

DeVita Says NCAB Subcommittee’s Recommendation For Reshaping Organ Site Program Is “Reasonable”

This article is from The Cancer Letter archive.

Vol. 08 No. 17 | April 23, 1982

Download PDF Visit The Full Archive

Related Articles

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006

FDA Issues MedWatch Warning, Begins Safety Review Of Prostate Cancer Drugs

May 7, 2010

Deborah Mayer Appointed To NCAB; Cancer Panel Plans Meetings For July 9

May 10, 1991

In Brief: Top Priority: Keep Rauscher; Pay Raise Bill No Moving; Miller, Holland Head AACR, ASCO

May 21, 1976

Amgen, Genentech Drug Giveaway Programs Likely to Meet Resistance From Doctors, Potential Problems at CMS.

October 13, 2006

Rogers-Kennedy Impasses Still Blocks Training Grant Bill

April 19, 1974